1. Home
  2. ARCT vs UFCS Comparison

ARCT vs UFCS Comparison

Compare ARCT & UFCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • UFCS
  • Stock Information
  • Founded
  • ARCT 2013
  • UFCS 1946
  • Country
  • ARCT United States
  • UFCS United States
  • Employees
  • ARCT N/A
  • UFCS N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • UFCS Property-Casualty Insurers
  • Sector
  • ARCT Health Care
  • UFCS Finance
  • Exchange
  • ARCT Nasdaq
  • UFCS Nasdaq
  • Market Cap
  • ARCT 320.8M
  • UFCS 806.8M
  • IPO Year
  • ARCT N/A
  • UFCS N/A
  • Fundamental
  • Price
  • ARCT $18.05
  • UFCS $31.67
  • Analyst Decision
  • ARCT Strong Buy
  • UFCS Buy
  • Analyst Count
  • ARCT 10
  • UFCS 2
  • Target Price
  • ARCT $50.88
  • UFCS $30.50
  • AVG Volume (30 Days)
  • ARCT 493.8K
  • UFCS 109.5K
  • Earning Date
  • ARCT 11-06-2025
  • UFCS 11-04-2025
  • Dividend Yield
  • ARCT N/A
  • UFCS 2.06%
  • EPS Growth
  • ARCT N/A
  • UFCS 143.32
  • EPS
  • ARCT N/A
  • UFCS 3.51
  • Revenue
  • ARCT $122,122,000.00
  • UFCS $1,322,727,000.00
  • Revenue This Year
  • ARCT N/A
  • UFCS $12.34
  • Revenue Next Year
  • ARCT $28.92
  • UFCS $14.56
  • P/E Ratio
  • ARCT N/A
  • UFCS $8.88
  • Revenue Growth
  • ARCT N/A
  • UFCS 14.18
  • 52 Week Low
  • ARCT $8.04
  • UFCS $19.19
  • 52 Week High
  • ARCT $25.88
  • UFCS $32.22
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 58.87
  • UFCS 58.65
  • Support Level
  • ARCT $16.54
  • UFCS $30.71
  • Resistance Level
  • ARCT $19.50
  • UFCS $32.22
  • Average True Range (ATR)
  • ARCT 1.08
  • UFCS 0.73
  • MACD
  • ARCT -0.08
  • UFCS -0.06
  • Stochastic Oscillator
  • ARCT 56.46
  • UFCS 72.36

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About UFCS United Fire Group Inc.

United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.

Share on Social Networks: